Prostate cancer: New therapies in the pipeline?
Open Access
- 4 June 1998
- journal article
- review article
- Published by Elsevier in Current Biology
- Vol. 8 (12) , R428-R430
- https://doi.org/10.1016/s0960-9822(98)70270-2
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Molecular cloning of human prostate specific antigen cDNAPublished by Wiley ,2001
- Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancerProceedings of the National Academy of Sciences, 1998
- Antisense inhibition of the PTI-1 oncogene reverses cancer phenotypesProceedings of the National Academy of Sciences, 1998
- Preliminary Imaging Results Using In-111 Labeled CYT-356 (Prostascintst) in the Detection of Recurrent Prostate CancerClinical Nuclear Medicine, 1996
- Characterization of a prostate carcinoma mucin‐like antigen (PMA)International Journal of Cancer, 1995
- Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display.Proceedings of the National Academy of Sciences, 1995
- Prostate cancer. An overview of an increasing dilemmaCancer, 1993
- Differential screening of a human pancreatic adenocarcinoma λgt11 expression library has identified increased transcription of elongation factor ef‐1α in tumour cellsInternational Journal of Cancer, 1992
- A novel prostate carcinoma‐associated glycoprotein complex (PAC) recognized by monoclonal antibody turp‐27International Journal of Cancer, 1991
- Hormonal Therapy of Prostatic CarcinomaCancer, 1990